Exact Sciences Corp (NAS:EXAS)
$ 50.38 -1.57 (-3.02%) Market Cap: 9.30 Bil Enterprise Value: 11.20 Bil PE Ratio: 0 PB Ratio: 2.96 GF Score: 78/100

Exact Sciences Corp at Stifel Virtual Healthcare Conference Transcript

Nov 16, 2020 / 02:20PM GMT
Release Date Price: $121.47 (-1.01%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Good morning, everybody. Welcome to the Stifel Life Science -- Healthcare Conference. I'm Dan Arias, life sciences and diagnostics analyst. This is our first life sciences session here with Exact Sciences. So welcome, Jeff, to our conference. I appreciate you taking the time to spend a bit of conversational time with us. It's certainly -- well, thanks for coming.

Let's start there. I hope you're well. Hope you're safe and (inaudible) by you.

Jeffrey T. Elliott
Exact Sciences Corporation - CFO

Thanks for having us, Dan.

Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

There's not a lot that -- there's a lot of good things to be said for Exact right now. There's certainly some -- plenty of interesting things going on. I thought what we could do, we have about 30 minutes, is to talk about Thrive. I'm sure that's gotten plenty of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot